Hyperthermic intraperitoneal chemotherapy for the treatment of recurrent ovarian cancer in elderly women

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: Upfront therapy, at first recurrence, or later?

(2013) L. Gonzalez Bayon et al.   EJSO

Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients

(2013) N. Bakrin et al.   EJSO

Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer

(2013) P. Cascales Campos et al.   EJSO

Faisabilité, morbidité et survie de la chirurgie avec CHIP dans la prise en charge des récidives du cancer de l’ovaire

(2013) E. Furet et al.   GYNECOLOGIE OBSTETRIQUE & FERTILITE

Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case–control study on survival in patients with two year follow-up

(2012) Anna Fagotti et al.   GYNECOLOGIC ONCOLOGY

Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: Results from the SOCRATES retrospective study

(2009) Sandro Pignata et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results

(2009) Terence C. Chua et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy

(2008) Rami Younan et al.   JOURNAL OF SURGICAL ONCOLOGY

Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy

(2008) Santiago González-Moreno et al.   JOURNAL OF SURGICAL ONCOLOGY